122 related articles for article (PubMed ID: 36669686)
1. T-Cell Mineralocorticoid Receptor Deficiency Attenuates Pathologic Ventricular Remodelling After Myocardial Infarction.
Wang YL; Ma XX; Li RG; Zhu H; Bai L; Du LJ; Zhu SW; Pan YT; Lin WZ; Liu Y; Liu Y; Zhang WW; Hou XM; Duan SZ
Can J Cardiol; 2023 May; 39(5):593-604. PubMed ID: 36669686
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction.
Wang YL; Bai L; Shi XR; Zhu H; Du LJ; Liu Y; Ma XX; Lin WZ; Liu T; Sun JY; Liu Y; Guo XG; Zhou LJ; Chen BY; Shao S; Meng XQ; Li YL; Li RG; Duan SZ
J Mol Cell Cardiol; 2022 Jun; 167():40-51. PubMed ID: 35314145
[TBL] [Abstract][Full Text] [Related]
3. Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
Shen ZX; Yang QZ; Li C; Du LJ; Sun XN; Liu Y; Sun JY; Gu HH; Sun YM; Wang J; Duan SZ
Atherosclerosis; 2018 Jul; 274():199-205. PubMed ID: 29800789
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction.
Yan X; Shichita T; Katsumata Y; Matsuhashi T; Ito H; Ito K; Anzai A; Endo J; Tamura Y; Kimura K; Fujita J; Shinmura K; Shen W; Yoshimura A; Fukuda K; Sano M
J Am Heart Assoc; 2012 Oct; 1(5):e004408. PubMed ID: 23316306
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2/Anti-Interleukin-2 Immune Complex Attenuates Cardiac Remodeling after Myocardial Infarction through Expansion of Regulatory T Cells.
Zeng Z; Yu K; Chen L; Li W; Xiao H; Huang Z
J Immunol Res; 2016; 2016():8493767. PubMed ID: 27144181
[TBL] [Abstract][Full Text] [Related]
6. C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
Wang Y; Dembowsky K; Chevalier E; Stüve P; Korf-Klingebiel M; Lochner M; Napp LC; Frank H; Brinkmann E; Kanwischer A; Bauersachs J; Gyöngyösi M; Sparwasser T; Wollert KC
Circulation; 2019 Apr; 139(15):1798-1812. PubMed ID: 30696265
[TBL] [Abstract][Full Text] [Related]
7. Macrophage neogenin deficiency exacerbates myocardial remodeling and inflammation after acute myocardial infarction through JAK1-STAT1 signaling.
Zhang J; Xu Y; Wei C; Yin Z; Pan W; Zhao M; Ding W; Xu S; Liu J; Yu J; Ye J; Ye D; Qin JJ; Wan J; Wang M
Cell Mol Life Sci; 2023 Oct; 80(11):324. PubMed ID: 37824022
[TBL] [Abstract][Full Text] [Related]
8. A sequential interferon gamma directed chemotactic cellular immune response determines survival and cardiac function post-myocardial infarction.
Finger S; Knorr M; Molitor M; Schüler R; Garlapati V; Waisman A; Brandt M; Münzel T; Bopp T; Kossmann S; Karbach S; Wenzel P
Cardiovasc Res; 2019 Nov; 115(13):1907-1917. PubMed ID: 30949687
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
10. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-23 deficiency leads to impaired wound healing and adverse prognosis after myocardial infarction.
Savvatis K; Pappritz K; Becher PM; Lindner D; Zietsch C; Volk HD; Westermann D; Schultheiss HP; Tschöpe C
Circ Heart Fail; 2014 Jan; 7(1):161-71. PubMed ID: 24300243
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Promotes Myocardial Repair after Myocardial Infarction.
Li YL; Hao WJ; Chen BY; Chen J; Li GQ
Chin Med J (Engl); 2018 Oct; 131(19):2302-2309. PubMed ID: 30246716
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon-Gamma.
Sun XN; Li C; Liu Y; Du LJ; Zeng MR; Zheng XJ; Zhang WC; Liu Y; Zhu M; Kong D; Zhou L; Lu L; Shen ZX; Yi Y; Du L; Qin M; Liu X; Hua Z; Sun S; Yin H; Zhou B; Yu Y; Zhang Z; Duan SZ
Circ Res; 2017 May; 120(10):1584-1597. PubMed ID: 28298295
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid Receptor Deficiency in T Cells Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction Through Modulating T-Cell Activation.
Li C; Sun XN; Zeng MR; Zheng XJ; Zhang YY; Wan Q; Zhang WC; Shi C; Du LJ; Ai TJ; Liu Y; Liu Y; Du LL; Yi Y; Yu Y; Duan SZ
Hypertension; 2017 Jul; 70(1):137-147. PubMed ID: 28559389
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
Bansal SS; Ismahil MA; Goel M; Zhou G; Rokosh G; Hamid T; Prabhu SD
Circulation; 2019 Jan; 139(2):206-221. PubMed ID: 30586716
[TBL] [Abstract][Full Text] [Related]
18. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
[TBL] [Abstract][Full Text] [Related]
19. A
Alter C; Ding Z; Flögel U; Scheller J; Schrader J
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H190-H200. PubMed ID: 31050560
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction.
Wang Y; Liu CL; Fang W; Zhang X; Yang C; Li J; Liu J; Sukhova GK; Gurish MF; Libby P; Shi GP; Zhang J
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1170-1181. PubMed ID: 30639224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
